Pharmaceutical sector Policy
The state of Jharkhand has identified the Pharmaceutical sector as a Thrust Sector in its Industrial Policy. The market value of the Pharma Industry in the state has grown from Rs 896 Cr in FY15 to Rs 1248 Cr in FY17. The market has grown on an average of 18% during the last 3 years. The state is contributing 5% of the market in East India and 1% of the overall Indian Pharmaceutical Market.
Jharkhand has the key resources: infrastructure, natural resources, cost-competitiveness, a sound policy and regulatory environment, required to create a conducive eco-system for the manufacturing industry and to attract investments in this sector.
A dedicated Pharma park having an area of 35 acres has been proposed to be established in Bijupara, Ranchi. The project is approved by the Ministry of MSME to tap the grant under Micro Small Enterprises – Cluster Development Programme- (MSE-CDP) scheme. Out of the 35 acres about 23 acres of land has been demarcated into 54 plots.
For the development of the Pharmaceutical Sector, the following incentives are proposed to the Pharma Units under this policy.
|
Incentive |
Provisions Proposed under this Policy |
|
Capital Incentives Subsidy |
25% of the FCI subject to the following limits. · Micro – Rs. 1 crore · Small – Rs. 5 crore · Medium – Rs. 10 crore · Non MSMEs – Rs. 25 crore. Additional 5% for SC/ST/Women/Differently abled Entrepreneurs |
|
Interest Subsidy |
Interest subsidy for timely payment @ 5% per annum on total loan availed for period of five years from date of commercial production subject to total maximum limit of · Rs. 15 Lakhs for Micro Enterprises · Rs. 50 Lakhs for Small Enterprises · Rs. 1 crore for Medium Enterprises · Rs. 3 Crores for non-MSME Sector units |
|
Stamp Duty & Registration Fee |
· 100% reimbursement |
|
SGST |
· New MSME units: 100% of the NET SGST amount paid for a period of 5 years subject to the maximum of 100% of total Fixed Capital investment made by the units · New Large units:100% of the NET SGST amount paid for a period of 7 years subject to the maximum of 100% of total Fixed Capital investment made by the units · New Mega units: 100% of the NET SGST amount paid for a period of 9 years subject to the maximum of 100% of total Fixed Capital investment made by the units · Ultra-mega units: 75% of the NET SGST amount paid for a period of 12 years subject to the maximum of 100% of total Fixed Capital investment made by the units |
|
Patent Registration |
· 50%, upto Rs 10 lakh per patent |
|
Quality Certification |
· 50%, upto Rs 10 lakh |
